Daniel J. O'Connor
CIK: 0001376847
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DMAC
DiaMedica Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About O'Connor Daniel J.
O'Connor Daniel J. (SEC CIK 0001376847) files insider reports with the SEC as Director of DiaMedica Therapeutics Inc. (DMAC).
Signal8 holds 3 ownership filings by O'Connor Daniel J. (1 Form 3, 2 Form 4), filed between Feb 24, 2025 and Jun 3, 2026. Those filings report 2 transactions, from Feb 20, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on O'Connor Daniel J.'s filings is in MINNEAPOLIS, MN.
Recent filings by O'Connor Daniel J.
Other insiders filing for DiaMedica Therapeutics Inc. (DMAC)
- Pauls Dietrich John, President & CEO
- Giuffre Randall Michael, Director
- Kuntz Richard, Director
- Lewis Tanya, Director
- Semba Charles Pauling, Director
- Parsons James T., Director